Meprobamate (Taro Pharmaceutical Industries Ltd.)
Welcome to the PulseAid listing for the Meprobamate drug offered from Taro Pharmaceutical Industries Ltd.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Taro Pharmaceutical Industries Ltd. |
| NON-PROPRIETARY NAME: | Meprobamate |
| SUBSTANCE NAME: | MEPROBAMATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-05-23 |
| END MARKETING DATE: | 0000-00-00 |
Meprobamate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Meprobamate from Taro Pharmaceutical Industries Ltd. |
| LABELER NAME: | Taro Pharmaceutical Industries Ltd. |
| DEA SCHEDULE: | CIV
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2011-05-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52549-4147_a1a2d874-5b9c-4f21-bb21-8757f2468b2a |
| PRODUCT NDC: | 52549-4147 |
| APPLICATION NUMBER: | ANDA200998 |
Other MEPROBAMATE Pharmaceutical Manufacturers / Labelers:
